Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-26-002415
Filing Date
2026-04-27
Accepted
2026-04-27 19:14:08
Documents
3
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 14623
2 d12145300_ex99-a.htm EX-99 5833
3 d12145300_ex99-b.htm EX-99 10508
  Complete submission text file 0000919574-26-002415.txt   33111
Mailing Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Filed by) CIK: 0001278386 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Subject) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89221 | Film No.: 26902660
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)